IL10 and allergic asthma: Thus, the induction of Tr1 cells and therefore IL-10 might be a new therapeutical aim in the treatment of allergic asthma since Tr1 cells inhibit airway hyperresponsiveness, amongst other features of allergic asthma (Akbari et al., 2001; Umetsu et al., 2002).